Relationship Between Final Height and Health Outcomes in Adults With Congenital Adrenal Hyperplasia: United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE)
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
CONTEXT: Treatment of congenital adrenal hyperplasia (CAH) in childhood focuses on growth and development and adult final height (FH) is a measure of effective treatment. We hypothesized that shorter adults will have more severe underlying disease and worse health outcomes. METHODS: This was a cross-sectional analysis of 199 adults with CAH. FH and quality of life were expressed as z-scores adjusted for midparental target height or UK population height. RESULTS: FH correlated inversely with age (men, r = -0.38; women, r = -0.26, P < .01). Men and women had z-scores adjusted for midparental target height of -2 and -1, respectively, and both groups had UK population height z-scores of -1 below the UK population (P < .01). In women, FH was shorter in non-salt-wasting than salt-wasting classic CAH (P < .05) and in moderately affected genotype group B women than either more severely affected groups null and A (P < .01) or the mildest group C (P < .001). Short stature and a higher prevalence of hypertension were observed in classic CAH patients diagnosed late (after 1 y) compared with those diagnosed early and in women treated with glucocorticoid only compared with those treated with both glucocorticoids and mineralocorticoids (P < .05). FH did not associate with insulin sensitivity, lipid profile, adiposity, or quality of life. CONCLUSIONS: Adult CAH patients remain short, although height prognosis has improved over time. The shortest adults are those diagnosed late with moderate severity CAH and are at increased risk of adult hypertension; we hypothesize that these patients are exposed in childhood to high androgens and/or excessive glucocorticoids with potential programming of hypertension. Another possibility is inadequate mineralocorticoid treatment early in life in the late-diagnosed patient group. Prospective studies are now required to examine these hypotheses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, achieving the optimal dose and timings of hydrocortisone replacement to avoid the adverse effects of excessive glucocorticoid on growth and metabolism while maintaining adequate androgen suppression is challenging, resulting in poor health outcomes (28).”
From ACTH Antagonists (2016) · cites this paper as [28]
In the citing paper
“Patients have an increased morbidity and mortality in adult life that may in part relate to suboptimal glucocorticoid therapy in their early years of life ( Finkielstain et al., 2012 ; Han et al., 2014 ; Bancos et al., 2015 ; Bornstein et al., 2016 ).”
From Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach (2023) · cites this paper as Han et al., 2014
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Gender differences in the regulation of blood pressure
Reckelhoff, J. F. (2001) · Hypertension · doi:10.1161/01.hyp.37.5.1199 · Cited by 1,268
Glucocorticoid exposure in utero: new model for adult hypertension
Benediktsson, R., Lindsay, R. S., Noble, J., Seckl, J. R., & Edwards, C. R. W. (1993) · The Lancet · doi:10.1016/0140-6736(93)90138-7 · Cited by 863
Sesso, H. D., Stampfer, M. J., Rosner, B., Hennekens, C. H., Gaziano, J. M., Manson, J. E., & Glynn, R. J. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.801 · Cited by 599
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Self-citationGlucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms
Seckl, J. R. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00633-5 · Cited by 392
Paajanen, T. A., Oksala, N. K. J., Kuukasjärvi, P., & Karhunen, P. J. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq155 · Cited by 335
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2102 · Cited by 313
Height, wealth, and health: An overview with new data from three longitudinal studies
Batty, G. D., Shipley, M. J., Gunnell, D., Huxley, R., Kivimaki, M., Woodward, M., Lee, C. M. Y., & Smith, G. D. (2009) · Economics & Human Biology · doi:10.1016/j.ehb.2009.06.004 · Cited by 235
Long Term Outcome in Adult Males with Classic Congenital Adrenal Hyperplasia1
Cabrera, M. S., Vogiatzi, M. G., & New, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7668 · Cited by 204
Eugster, E. A., DiMeglio, L. A., Wright, J. C., Freidenberg, G. R., Seshadri, R., & Pescovitz, O. H. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.110527 · Cited by 197
Gidlöf, S., Falhammar, H., Thilén, A., von Döbeln, U., Ritzén, M., Wedell, A., & Nordenström, A. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70007-x · Cited by 187
Adult Height in Patients with Congenital Adrenal Hyperplasia: A Systematic Review and Metaanalysis
Muthusamy, K., Elamin, M. B., Smushkin, G., Murad, M. H., Lampropulos, J. F., Elamin, K. B., Abu Elnour, N. O., Gallegos-Orozco, J. F., Fatourechi, M. M., Agrwal, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2616 · Cited by 182
Fetal and infant origins of cardiovascular disease.
Barker, D. J. P., & Fall, C. H. D. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.68.6.797 · Cited by 171
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1350 · Cited by 167
Short Stature and the Risk of Adiposity, Insulin Resistance, and Type 2 Diabetes in Middle Age
Asao, K., Kao, W. H. L., Baptiste-Roberts, K., Bandeen-Roche, K., Erlinger, T. P., & Brancati, F. L. (2006) · Diabetes Care · doi:10.2337/dc05-1997 · Cited by 151
Approach to the patient: the adult with congenital adrenal hyperplasia
Auchus, R. J., & Arlt, W. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1440 · Cited by 121
Self-citationKrone, N., Rose, I. T., Willis, D. S., Hodson, J., Wild, S. H., Doherty, E. J., Hahner, S., Parajes, S., Stimson, R. H., Han, T. S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3343 · Cited by 119
ROLE OF ANDROGENS IN MEDIATING HYPERTENSION AND RENAL INJURY
Reckelhoff, J. F., & Granger, J. P. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.02996.x · Cited by 110
Falhammar, H., Filipsson Nyström, H., Wedell, A., & Thorén, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0877 · Cited by 103
Nakagawa, K., Marji, J. S., Schwartzman, M. L., Waterman, M. R., & Capdevila, J. H. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00459.2002 · Cited by 92
Mooij, C. F., Kroese, J. M., Claahsen‐van der Grinten, H. L., Tack, C. J., & Hermus, A. R. M. M. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03690.x · Cited by 92
Lee, C. M. Y., Barzi, F., Woodward, M., Batty, G. D., Giles, G. G., Wong, J. W., Jamrozik, K., Lam, T. H., Ueshima, H., Kim, H. C., et al. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp150 · Cited by 82
Florêncio, T. T., Ferreira, H. S., Cavalcante, J. C., & Sawaya, A. L. (2004) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(04)80044-9 · Cited by 79
Han, T. S., Krone, N., Willis, D. S., Conway, G. S., Hahner, S., Rees, D. A., Stimson, R. H., Walker, B. R., Arlt, W., Ross, R. J., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0128 · Cited by 79
Self-citationLong Term Outcome in Adult Males With Classic Congenital Adrenal Hyperplasia
Jarow, J. P. (2002) · The Journal of Urology · doi:10.1097/00005392-200208000-00120 · Cited by 77
Final Adult Height in Children with Congenital Adrenal Hyperplasia Treated with Growth Hormone
Lin-Su, K., Harbison, M. D., Lekarev, O., Vogiatzi, M. G., & New, M. I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2699 · Cited by 75
Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Stimson, R. H., Rees, D. A., Krone, N., Willis, D. S., Conway, G. S., Arlt, W., Walker, B. R., Ross, R. J., & (CaHASE), U. K. C. A. H. A. S. E. (2013) · Clinical Endocrinology · doi:10.1111/cen.12045 · Cited by 70
Self-citationShort stature and hypertension in the city of Rio de Janeiro, Brazil
Sichieri, R., Siqueira, K. S., Pereira, R. A., & Ascherio, A. (2000) · Public Health Nutrition · doi:10.1017/s1368980000000094 · Cited by 68
Standards for Children's Height at Age 2 to 9 years allowing for height of Parents
Tanner, J. M., Goldstein, H., & Whitehouse, R. H. (1970) · Archives of Disease in Childhood · doi:10.1136/adc.45.244.819-b · Cited by 67
Wu, C., Cheng, J., Zhang, F. F., Gotlinger, K. H., Kelkar, M., Zhang, Y., Jat, J. L., Falck, J. R., & Schwartzman, M. L. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.161570 · Cited by 59
Langenberg, C., Hardy, R., Breeze, E., Kuh, D. J., & Wadsworth, M. E. J. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi071 · Cited by 53
Bonfig, W., Schmidt, H., & Schwarz, H. (2010) · Hormone Research in Paediatrics · doi:10.1159/000316973 · Cited by 44
Skeletal proportions and metabolic disorders in adults
Han, T. S., Hooper, J., Morrison, C., & Lean, M. E. J. (1997) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600479 · Cited by 43
Nermoen, I., Brønstad, I., Fougner, K. J., Svartberg, J., Øksnes, M., Husebye, E. S., & Løvås, K. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0196 · Cited by 43
Body morphology and ill health
Han, T. S. (1997) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.71292 · Cited by 1
Cited by
Tamhane, S., Rodriguez-Gutierrez, R., Iqbal, A. M., Prokop, L. J., Bancos, I., Speiser, P. W., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01862 · Cited by 123
“, 2014 (30) United Kingdom Cross-sectional Adults 199 NA”
InfluentialImpact of short stature on quality of life: A systematic literature review
Backeljauw, P. F., Cappa, M., Kieß, W., Law, L., Cookson, C., Sert, C., Whalen, J. D., & Dattani, M. (2021) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2021.101392 · Cited by 115
“Generic HRQoL was significantly poorer in adults with skeletal dysplasia [41], childhood-onset multiple pituitary hormone deficiency [44] and congenital adrenal hyperplasia (CAH) [42] than in healthy control groups.”
BackgroundMethodInfluentialHan, T. S., Krone, N., Willis, D. S., Conway, G. S., Hahner, S., Rees, D. A., Stimson, R. H., Walker, B. R., Arlt, W., Ross, R. J., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0128 · Cited by 79
Self-citationKing, T. F. J., Lee, M. C., Williamson, E. E. J., & Conway, G. S. (2016) · Clinical Endocrinology · doi:10.1111/cen.13001 · Cited by 66
Self-citationTorky, A., Sinaii, N., Jha, S., Desai, J., El‐Maouche, D., Mallappa, A., & Merke, D. P. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab133 · Cited by 84
“In a cross-sectional study of 199 adults with CAH in the United Kingdom, short stature was associated with hypertension (31); however, we did not find a relationship between adult height and hypertension or metabolic syndrome in our cohort.”
Background
Metadata
- Authors
- Han, T. S., Conway, G. S., Willis, D. S., Krone, N., Rees, D. A., Stimson, R. H., Arlt, W., Walker, B. R., Ross, R. J., & (CaHASE), T. U. K. C. A. H. A. S. E.
- Affiliations
- National Health Service (GB)
- University College Hospital (GB)
- Society for Endocrinology (GB)
- University of Birmingham (GB)
- Centre for Endocrine and Diabetes Sciences (D.A.R.), Institute for Molecular and Experimental Medicine, Cardiff University, Cardiff CF10 3US, United Kingdom
- The Queen's Medical Research Institute (GB)
- University of Sheffield (GB)
- Corresponding author
- Ross, R. J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-08-01
- Volume
- 99
- Issue
- 8
- Pages
- E1547-E1555
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2102643461
- Cited by
- 65
- References
- 41
- Citations by year
- 2025: 7 · 2024: 6 · 2023: 9 · 2022: 6 · 2021: 5 · 2020: 2 · 2019: 6 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 3 · 2014: 1
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- British Heart Foundation (RG/11/4/28734)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- congenital adrenal hyperplasia, short stature, hypertension, mineralocorticoid therapy, glucocorticoid therapy, disease severity, genotypes, diagnosis timing, health outcomes, quality of life, insulin sensitivity, lipid profile, adiposity, developmental programming
- MeSH terms
- Adrenal Hyperplasia, Congenital, Adult, Body Height, Cardiovascular Diseases, Cross-Sectional Studies, Female, United Kingdom, Humans, Male, Middle Aged, Prognosis, Risk Factors, Severity of Illness Index, Cohort Studies, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.